clinical safety & effectiveness cohort #17

37
1 Clinical Safety & Effectiveness Cohort #17 Delayed Cord Clamping Team 7 DATE

Upload: others

Post on 26-May-2022

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Clinical Safety & Effectiveness Cohort #17

1

Clinical Safety & EffectivenessCohort #17

Delayed Cord Clamping

Team 7

DATE

Page 2: Clinical Safety & Effectiveness Cohort #17
Page 3: Clinical Safety & Effectiveness Cohort #17

3

The Team– Amy Quinn MD– Margarita Vasquez MD – Michael Sorrell DO– Richard Stribley MD– Sartaj Siddiqui DO– Patrick Ramsey MD– Kayla Ireland MD– Adriana Perez– Melanie Baker

– Irma Sanchez– Rachel Farner– Rachel Rivas– Irene Sandate– Iba Aburizik

Sponsor Department: Department of Pediatrics, Division of Neonatology, Dr. Steven Seidner

Page 4: Clinical Safety & Effectiveness Cohort #17

Team Picture

4

Page 5: Clinical Safety & Effectiveness Cohort #17

History of Cord Clamping

• 1790 – Erasmus Darwin – “Another thing very injurious to the child is the tying and

cutting of the navel string too soon, which should always be left till the child has not only repeatedly breathed but till all pulsation in the cord ceases. As otherwise the child is much weaker than it ought to be, a part of the blood being left in the placenta which ought to have been in the child and at the same time the placenta does not so naturally collapse, and withdraw itself from the sides of the uterus, and is not therefore removed with so much safety and certainty.”

Page 6: Clinical Safety & Effectiveness Cohort #17

History of Cord Clamping

• Mid 20th Century– Cord clamping begins to occur earlier– Theories

• More women delivering in hospitals• More obstetricians conducting deliveries• An increasing number of surgical deliveries

• 1960s - Active Management of Third Stage of Labor– The overall goal of preventing maternal postpartum hemorrhage

• Administration of a prophylactic uterotonic agent• Clamping and cutting the umbilical cord shortly after birth• Controlled cord traction of the umbilical cord

Page 7: Clinical Safety & Effectiveness Cohort #17

Early Cord Clamping

• Over a period of several years in the 60s and with relatively minimal scientific evidence of benefit, ECC became the norm

• DCC was “discarded from mainstream practice without careful study or regard to the physiologic processes at work.”

Page 8: Clinical Safety & Effectiveness Cohort #17

8

Aim Statement

We aim to achieve 50% implementation of a delayed cord clamping protocol at University Hospital in our target preterm neonate population by December 1st, 2015.

Page 9: Clinical Safety & Effectiveness Cohort #17

Clinical Benefits• Intraventricular Hemorrhage

– For every 100 babies who undergo delayed cord clamping < 37 weeks:

• Approximately 7-9 cases of IVH will be prevented • Approximately 22 cases of IVH will be prevented if only babies

< 32 weeks are considered• Mean Blood Pressure/Need for Inotropic Support

– Mean arterial blood pressures significantly improved at birth and at 4 hours of life with delayed cord clamping

– Less inotropic support required with DCC (Rabe et al) • Early cord clamping – 22 patients • Delayed cord clamping – 9 patients

9

Page 10: Clinical Safety & Effectiveness Cohort #17

Clinical Benefits

• Blood Transfusions– For every 100 patients who receive DCC:

• 26-33 babies will be spared at least one subsequent blood transfusion

• Up to 45 babies spared transfusion in one study (Kinmond et al.); these patients were of a younger gestational age and on ventilators

• Admission Hematocrit: Higher with DCC– Initial Hematocrit: DCC – 51%, ECC – 46%– Hematocrit at 24hrs of life: DCC – 55%, ECC – 51%

10

Page 11: Clinical Safety & Effectiveness Cohort #17

Clinical Benefits

• Rates of sepsis significantly LOWER in children who undergo delayed cord clamping – Potentially due to increased transfer of maternal

immunoglobulins, or stem cells

• Total NEC events LESS when patients underwent delayed cord clamping:– Early cord clamping – 39 NEC events– Delayed cord clamping – 24 NEC events

Page 12: Clinical Safety & Effectiveness Cohort #17

The potential for harm needs to be weighed by clinicians in context within the settings in

which they work

Page 13: Clinical Safety & Effectiveness Cohort #17

Safety Concerns

• Primary safety concerns have been addressed in literature extensively in multiple studies totaling over 4,000 randomized neonates

• No difference in:– APGARs– Admission Temperature– Need for phototherapy– Need for an exchange transfusion

13

Page 14: Clinical Safety & Effectiveness Cohort #17

Current Position

• Basic Newborn Resuscitation Guideline 2012• “In newly-born term babies who do not require positive-

pressure ventilation, the cord should not be clamped earlier than one minute after birth”

• Strong recommendation based on evidence of high to moderate quality

• WHO Recommendations for the prevention of postpartum haemorrhage state that the cord should not be clamped earlier than is necessary for applying cord traction (around 3 minutes)

Page 15: Clinical Safety & Effectiveness Cohort #17

Kim et al., Neoreviews, 2015

Page 16: Clinical Safety & Effectiveness Cohort #17

16

Project Milestones

• Team Created August 2015• AIM statement created August 2015• Weekly Team Meetings Aug to Dec 2105• Background Data, Brainstorm Sessions, Sept 2015

Workflow and Fishbone Analyses• Interventions Implemented Oct 5th, 2015• Data Analysis Dec 2015• CS&E Presentation Jan 2016

Page 17: Clinical Safety & Effectiveness Cohort #17

Cord Clamping Process Evaluation

Page 18: Clinical Safety & Effectiveness Cohort #17

18

Process Evaluation

Page 19: Clinical Safety & Effectiveness Cohort #17

19

PLAN: Intervention

Page 20: Clinical Safety & Effectiveness Cohort #17

20

PLAN: Intervention

Page 21: Clinical Safety & Effectiveness Cohort #17

DO: Implementation

• Developed the intervention flow sheet and data collection form in early August

• Started teaching NICU and L&D nurses in FYI weekly meetings mid August

• Informing and teaching faculty and fellows in morning report meetings in September

• Implementation of delayed cord clamping occurred October 1, 2015

21

Page 22: Clinical Safety & Effectiveness Cohort #17

CHECK: RESULTS/IMPACT

22

Page 23: Clinical Safety & Effectiveness Cohort #17

23

Cord Clamping DelayedPost-Intervention

Yes71%

No29%

Page 24: Clinical Safety & Effectiveness Cohort #17

24

UCL 1.0

0.0

CL 0.20.0

LCL -0.6

0.0

-1.0

-0.5

0.0

0.5

1.0

1.5

2.0

2.5

3.0

3.5

num

ber o

f pRB

Cs

Date of birth

Number of pRBC Transfusions in First 7 Days of Life

Intervention

Page 25: Clinical Safety & Effectiveness Cohort #17

25

UCL 68.765.6

CL 45.7

50.7

LCL 22.6

35.8

15.0

25.0

35.0

45.0

55.0

65.0

75.0

HCT

-ini

tial

Date of birth

Initial Hematocrit

Intervention

Page 26: Clinical Safety & Effectiveness Cohort #17

26

UCL 72.3 71.7

CL 43.745.6

LCL 15.1

19.6

5.6

15.6

25.6

35.6

45.6

55.6

65.6

75.6

85.6

MAP

Adm

it

Date of birth

Mean Arterial Pressure at Admission

Intervention

Page 27: Clinical Safety & Effectiveness Cohort #17

27

UCL 99.83

98.79

CL 97.9997.80

LCL 96.15

96.80

95.3

95.8

96.3

96.8

97.3

97.8

98.3

98.8

99.3

99.8

100.3

Adm

issi

on te

mp

Date of birth

Admission Temperature

Intervention

Page 28: Clinical Safety & Effectiveness Cohort #17

28

UCL 12.6

11.0

CL 7.27.5

LCL 1.9

4.0

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

1 m

in A

pgar

Date of birth

One Minute Apgar

Intervention

Page 29: Clinical Safety & Effectiveness Cohort #17

29

UCL 11.3 11.1

CL 8.18.3

LCL 5.0

5.5

3.0

4.0

5.0

6.0

7.0

8.0

9.0

10.0

11.0

12.0

5 m

in A

pgar

Date of birth

Five Minute Apgar

Intervention

Page 30: Clinical Safety & Effectiveness Cohort #17

30

UCL 9.01

11.64

CL 4.90

6.10

LCL 0.78 0.56

0.0

2.0

4.0

6.0

8.0

10.0

12.0

14.0

Bilir

ubin

Date of birth

Peak Total Bilirubin in first 24 Hours of Life

Page 31: Clinical Safety & Effectiveness Cohort #17

31

Return on Investment

• Both Measurable and immeasurable benefits exist in this study

• Improvements in communication between NICU and Labor and Delivery are a byproduct of DCC project

Page 32: Clinical Safety & Effectiveness Cohort #17

32

Return on Investment

Direct Cost Savings:– Evidence estimates approximately 25-30

blood transfusion are prevented for every 100 premature infants who undergo DCC

– Each blood transfusion in the NICU costs approximately $900

– Each year, DCC is estimated to save the UHS NICU approximately $81,000

J Perinatol. 2015 Feb;35(2):132-6. doi: 10.1038/jp.2014.171. Epub 2014 Sep 25.

Page 33: Clinical Safety & Effectiveness Cohort #17

Lessons Learned

• Build a team of invested individuals and then involve team every step of the way

• Implementing a change in clinical practice will take much longer/will be much harder then you think

• Project success depends on gaining “Buy In” from nursing staff and administration

33

Page 34: Clinical Safety & Effectiveness Cohort #17

ACT: Sustaining the Results

• Team will continue to refine clinical protocol to ensure sustained increase in rates of delayed cord clamping in appropriate patients by:– Continued education/training of medical staff – through

weekly “FYI” meetings with nursing staff, “Morning Report” of medical staff

– Continue to ensure adequate communication between NICU and OB teams

– Adjust protocol when necessary to suit delivery room environment

34

Page 35: Clinical Safety & Effectiveness Cohort #17

Future Plans

• Once clinical protocol fully integrated into standard of care, plan is to expand target population

• In next 2-3 months, target population will be expanded to include infants 26 0/7 weeks and older

• Ultimate goal is to perform Delayed Cord Clamping on All premature infants born at University Hospital

35

Page 36: Clinical Safety & Effectiveness Cohort #17

36

Thank you!

Page 37: Clinical Safety & Effectiveness Cohort #17

Questions?